Oxidative protein damage and degradation in lymphocytes from patients infected with human immunodeficiency virus

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 655-664

  Piedimonte, Giuseppe ^a   Guetard, Denise ^b   Magnani, Mauro ^b   Corsi, Dario ^b   Picerno, Isa ^b   Spataro, Pasquale ^b   Kramer, Laura ^b   Montroni, Maria ^b   Silvestri, Guido ^b   Roca, Javier F Torres ^b   Montagnier, Luc ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MANGANESE SUPEROXIDE DISMUTASE; UBIQUITIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOGENESIS; MITOSIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; T LYMPHOCYTE ACTIVATION;

EID: 16944367062     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514087     Document Type: Article

References (10)

1. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation on NF-kB transcription factor and HIV-1. EMBO J 1991;10:2247-58.
2. Legrand-Poels S, Vaira D, Pincemail J, Van de Vorst A, Piette J. Activation of human immunodeficiency virus type I by oxidative stress. AIDS Res Hum Retrovir 1990;6:1389-7.
3. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester and N-acetylcysteine. Proc Natl Acad Sci USA 1991;88:986-90.
4. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-L-acetyl-cysteine. Proc Natl Acad Sci USA 1990;87:4884-8.
5. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
6. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339:909-12.
7. Cirelli A, Ciardi M, De Simone C, et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991;24:211-4.
8. Leff JA, Oppegard MA, Curiel TJ, Brown KS, Schooley RT, Repine JE. Progressive increase in serum catalase activity in advancing human immunodeficiency virus infection. Free Radic Biol Med 1992;13:143-9.
9. Revillard PJ, Vincent CMA, Favier AE, Richard MJ, Zittoun M, Kazatchkine MDJ. Lipid peroxidation in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1992;5:637-8.
10. Droge W, Eck HP, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today 1992;13:211-3.